CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 38 enrolled
Drug / intervention
rTMSdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04123496
NCT04123496N/ACompleted

Safety and Efficacy of an Accelerated Protocol of Intermittent Theta Burst Transcranial Magnetic Stimulation (TMS) to Enhance Performance and Promote Resilience in Astronauts: Study 1

Medical University of South Carolina·interventional·Posted Oct 11, 2019·Updated Oct 16, 2025

In Brief

A clinical study evaluating rTMS for Cognition and Stress Reaction. Completed, enrolled 38 participants across 1 site.

Detailed Summary

The purpose of this study is to determine the most effective dose of brief, non-invasive brain stimulation (repetitive transcranial magnetic stimulation, rTMS) for improving cognitive functions such as attention and memory as well as to improve the ability to recover from stressful situations (stress resilience).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedOct 11, 2019
Enrollment StartNov 21, 2019
Primary CompletionSep 27, 2021
Study CompletionOct 27, 2021
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 6.7 years ago

Interventions

rTMSdevice

Device: Repetitive Transcranial Magnetic Stimulation (rTMS) MagVenture MagPro TMS System would be utilized to deliver 3-minute sessions of intermittent theta burst to left dorsolateral prefrontal cortex.